{"title":"Navigating treatment dilemmas in severe paediatric IDA: A case report.","authors":"Rachel Fagen, Rachel Howard, Matthew Speckert","doi":"10.1093/pch/pxaf091","DOIUrl":null,"url":null,"abstract":"<p><p>Iron deficiency anemia (IDA) is a leading cause of anemia worldwide, often managed with oral iron. Severe paediatric cases, however, raise uncertainty about when to use packed red blood cell (pRBC) transfusion versus intravenous (IV) iron. We report a 16-year-old male with autism spectrum disorder and severe nutritional IDA (hemoglobin 31 g/L) who presented with tachycardia and hypotension but no acute decompensation. Although transfusion was discussed, the patient declined, and he was managed with IV iron followed by oral supplementation. Hemoglobin recovery was brisk, rising by 13 g/L within 5 days, but functional recovery was slow, taking 6 months. This case highlights the therapeutic dilemma in adolescents with chronic severe IDA who may meet criteria for transfusion yet remain clinically stable. IV iron offers a viable alternative in this setting, but paediatric guidelines are needed to better define transfusion thresholds and the role of IV iron.</p>","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"31 2","pages":"95-97"},"PeriodicalIF":2.5000,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12976666/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Paediatrics & child health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/pch/pxaf091","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Iron deficiency anemia (IDA) is a leading cause of anemia worldwide, often managed with oral iron. Severe paediatric cases, however, raise uncertainty about when to use packed red blood cell (pRBC) transfusion versus intravenous (IV) iron. We report a 16-year-old male with autism spectrum disorder and severe nutritional IDA (hemoglobin 31 g/L) who presented with tachycardia and hypotension but no acute decompensation. Although transfusion was discussed, the patient declined, and he was managed with IV iron followed by oral supplementation. Hemoglobin recovery was brisk, rising by 13 g/L within 5 days, but functional recovery was slow, taking 6 months. This case highlights the therapeutic dilemma in adolescents with chronic severe IDA who may meet criteria for transfusion yet remain clinically stable. IV iron offers a viable alternative in this setting, but paediatric guidelines are needed to better define transfusion thresholds and the role of IV iron.
期刊介绍：
Paediatrics & Child Health (PCH) is the official journal of the Canadian Paediatric Society, and the only peer-reviewed paediatric journal in Canada. Its mission is to advocate for the health and well-being of all Canadian children and youth and to educate child and youth health professionals across the country.
PCH reaches 8,000 paediatricians, family physicians and other child and youth health professionals, as well as ministers and officials in various levels of government who are involved with child and youth health policy in Canada.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
